ArticlePloS one2013

Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia.

Susanne Badura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.